Genetics of congenital lipodystrophies

Annales d'endocrinologie
A BuffetP Caron

Abstract

Congenital lipodystrophies are heterogeneous genetic diseases, leading to the loss of adipose tissue. This loss of adipose tissue can be generalized or partial, thus defining different phenotypes. These lipodystrophies have a major metabolic impact, secondary to lipotoxicity. This lipotoxicity is responsible for insulin resistance, dyslipidemia and hepatic steatosis. The severity of the metabolic impact correlates with the severity of the loss of adipose tissue. Mutations in 15 predisposition genes are currently described; BSCL2 and AGPT2 genes are the major genes in the generalized forms. On the contrary, LMNA and PPARG gene mutations are recovered in partial lipodystrophies forms. These different genes encode for proteins involved in adipocyte physiology, altering adipocyte differentiation, triglycerides synthesis and lysis or playing a major role in the lipid droplet formation. Congenital lipodystrophies treatment is based on the management of metabolic comorbidities but recombinant leptin therapy appears to have promising results. These different points have been recently discussed during the 2015 Endocrine Society Congress, notably by S. O'Rahilly and are highlighted in this review.

References

Oct 4, 2002·Journal of Medical Genetics·L Van MaldergemS O'Rahilly
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Anil K AgarwalAbhimanyu Garg
Aug 23, 2007·The Journal of Clinical Endocrinology and Metabolism·Aurélie DecaudainCorinne Vigouroux
Jan 24, 2008·The Journal of Clinical Endocrinology and Metabolism·C A KimJocelyne Magré
Apr 14, 2009·Biochemical and Biophysical Research Communications·Hideo ShindouTakao Shimizu
Jan 6, 2010·EMBO Molecular Medicine·Oscar Rubio-CabezasUNKNOWN LD Screening Consortium
Feb 25, 2011·The New England Journal of Medicine·Sheetal GandotraCorinne Vigouroux
Sep 2, 2011·The Journal of Clinical Investigation·Akiko KitamuraKoji Yasutomo
Jun 22, 2012·Human Molecular Genetics·Jemima BarrowmanSusan Michaelis
Aug 8, 2013·Orphanet Journal of Rare Diseases·Birgit KnebelDirk Muller-Wieland
Sep 13, 2013·BMC Medical Genetics·Anna ArdissoneMarina Mora
Feb 11, 2014·The Journal of Biological Chemistry·Shi-Ying DingPaul F Pilch
Jun 4, 2014·Proceedings of the National Academy of Sciences of the United States of America·Felicity PayneDavid B Savage
Sep 23, 2014·The International Journal of Biochemistry & Cell Biology·Mervi T Hyvönen, Kirsty L Spalding
Dec 6, 2014·The Canadian Journal of Cardiology·Sali M K FarhanRobert A Hegele

❮ Previous
Next ❯

Citations

Dec 27, 2019·Atherosclerosis·Nathalie Bonello-PalotLaurent Bonello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Endocrinology and Metabolism
Abhimanyu Garg
Annual Review of Genomics and Human Genetics
Anil K Agarwal, Abhimanyu Garg
The Journal of Clinical Endocrinology and Metabolism
Abhimanyu Garg, Anoop Misra
© 2022 Meta ULC. All rights reserved